Eleven Therapeutics Raises $22m Series Seed
In the News
2/8/2022
London, UK
Round includes $9 Million from the Bill & Melinda Gates Foundation, aimed at ushering in the next generation of RNAi therapeutics
https://medium.com/@eleventx/eleven-therapeutics-announces-22-million-in-seed-funding-7a51cbc1bce7
Related Resources
Blog
02.11.2026
The SaaS Reckoning: Surviving the AI Token Revolution
Public SaaS faces a structural reckoning as valuations plunge while the market demands autonomous execution. To survive this "Fork in the Road," incumbents must evolve from mere Systems of Record into Systems of Context. By moving beyond organizing work to actually completing it, software can finally bridge the AI value gap.
Press Release
01.28.2026
Zocks, raises $45m Series B to Expand its Agentic AI for Financial Advisors
Congrats to portfolio company Zocks on its $45m Series B. Trusted by thousands of advisors and firms of every size, Zocks has unique product market fit with its AI solution that saves financial advisors tens of hours each month.
Blog
11.21.2025
Sensi.ai’s $100M Journey: Vertical AI Shaping the Future of Care Intelligence
The world’s population is aging rapidly yet most seniors want to remain at home rather than move into retirement facilities . Yet, 89 % of home‑care providers have had to turn away new clients because they cannot find caregivers. This “care gap” is exactly the kind of challenge that vertical AI industry‑specific systems can potentially solve, so Entrée Capital invested in Sensi.ai to solve these challenges.